andrewkaretas, Author at Allogene - Page 7 of 15

March 6, 2024 9:10 AM EST : TD Cowen March 2024 Health Care Conference

Post author:andrewkaretas
Post published:February 28, 2024
Post category:Events

Continue Reading

February 14, 2024 12:00 PM EST : Oppenheimer 34th Annual Healthcare Life Sciences Conference

Post author:andrewkaretas
Post published:February 6, 2024
Post category:Events

Continue Reading

February 7, 2024 11:30 AM EST : Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Post author:andrewkaretas
Post published:January 31, 2024
Post category:Events

Continue Reading

January 18, 2024 3:30 PM EST : 2024 B Riley Virtual Oncology Conference

Post author:andrewkaretas
Post published:January 18, 2024
Post category:Events

Continue Reading

January 10, 2024 5:15 AM EST : Allogene Therapeutics J.P. Morgan Healthcare Conference Webcast

Post author:andrewkaretas
Post published:January 8, 2024
Post category:Events

Continue Reading

January 4, 2024 5:00 PM EST : Allogene Therapeutics 2024 Platform Vision Conference Call

Post author:andrewkaretas
Post published:January 3, 2024
Post category:Events

Continue Reading

Read more about the article Cellular Mechanisms Affecting Allogeneic CAR T Cell Expansion and Rejection in Large B-cell Lymphoma<sup>*</sup>

Cellular Mechanisms Affecting Allogeneic CAR T Cell Expansion and Rejection in Large B-cell Lymphoma^*

Post author:andrewkaretas
Post published:December 11, 2023
Post category:CD19 Scientific Publications

*In collaboration with The University of Texas MD Anderson Cancer Center.

Continue Reading

$Read more about the article ALLO‑647 for Lymphodepletion in the Allogeneic CAR T Cell Setting: Safety Experience With ALLO‑501‌ /‌ 501A in Patients With Relapsed / Refractory Large B-Cell and Follicular Lymphomas$

ALLO‑647 for Lymphodepletion in the Allogeneic CAR T Cell Setting: Safety Experience With ALLO‑501‌ /‌ 501A in Patients With Relapsed / Refractory Large B-Cell and Follicular Lymphomas

Post author:andrewkaretas
Post published:December 9, 2023
Post category:ALLO-647 Scientific Publications

Continue Reading

Read more about the article Unlocking the Fourth Great Wave in Cancer Treatment

Unlocking the Fourth Great Wave in Cancer Treatment

Post author:andrewkaretas
Post published:November 8, 2023
Post category:Perspectives

Continue Reading

Read more about the article Preclinical Evaluation of Allogeneic CD19 CAR T Cells Expressing an Anti-Rejection CD70 CAR

Preclinical Evaluation of Allogeneic CD19 CAR T Cells Expressing an Anti-Rejection CD70 CAR

Post author:andrewkaretas
Post published:November 2, 2023
Post category:Dual PLATFORM Scientific Publications

Continue Reading